Tag: side effects
-
GLP-1 Lawsuits Involving NAION Filed in Federal Court: 200 Cases as of August 2026
Patients Using Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound Seek Legal Compensation for Vision Loss (Posted by Tom Lamb at Drug Injury Watch) In December 2025, GLP-1 lawsuits involving NAION filed in federal court were consolidated by the…
-
Wegovy and Ozempic Vision Loss: Wegovy Rate 5x Higher vs. Ozempic, Men 3x More Often vs. Women
Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Semaglutide Study 2026 Data Analysis (Posted by Tom Lamb at Drug Injury Watch) A March 2026 British Journal of Ophthalmology medical journal article, “Ischemic optic neuropathy with semaglutide: global observational analysis…
-
Rybelsus Deep Vein Thrombosis Case Report: Medical Journal, 2026
Rybelsus (Semaglutide) Associated With Significantly Increased Risk Of Blood Clots (Posted by Tom Lamb at Drug Injury Watch) In this post, we point out a recent medical journal article that discusses a Rybelsus deep vein thrombosis case…
-
“New” Blood Clots Side Effect of Semaglutide Weight Loss Drugs Like Ozempic: Deep Vein Thrombosis
Research Finding: Semaglutide Increased the Risk of Deep Vein Thrombosis (DVT) by 266% in Patients with Type 2 Diabetes (Posted by Tom Lamb at Drug Injury Watch) UPDATE No Warnings About Blood Clots From Ozempic,…
-
Prolia Increased Risk Of Hypocalcemia In Patients With Chronic Kidney Disease (CKD) Can Be 20-Times Higher Than Pills
Prolia "Black Box" Warning: Harm From Severe Hypocalcemia Ranges From Hospitalization For Life-threatening Events To Death (Posted by Tom Lamb at Drug Injury Watch) A January 2024 JAMA Original Investigation article, "Severe Hypocalcemia With Denosumab…
-
Syfovre Update: New Warnings About Retinal Vasculitis and/or Retinal Vascular Occlusion After Syfovre Injections
November 2023 Syfovre Label Change Comes After Earlier Reports of Eye Inflammation and Severe Vision Loss (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites…
-
Ozempic, Wegovy, Other GLP-1 Semaglutide Weight-Loss Drugs Linked to Gastroparesis in Recent Medical Study
Researchers Compared Semaglutide Drugs, Such as Ozempic and Wegovy, to Contrave, a Non-GLP-1 Drug, in Weight-Loss Patients (Posted by Tom Lamb at Drug Injury Watch) An October 2023 medical journal article presented the results of…
-
Severe Stomach Conditions in Patients Using Semaglutide Weight Loss Drugs From Novo Nordisk
Ozempic, Rybelsus, and Wegovy Use Might Cause Gastroparesis, Gastric Stasis, or Stomach Paralysis (Posted by Tom Lamb at Drug Injury Watch) Semaglutide is the active ingredient in three Novo Nordisk drugs that are being used…